Over 250 ready-to-use clinical reagents, optimised for use on Roche Diagnostics' staining platforms

Roche Diagnostics antibodies, including our breast panel, cover the diagnostic requests in pathology. Roche Diagnostics antibodies include IVD/CE-IVD antibodies, as well as novel antibodies still in the research phase.

Staining analysis is facilitated by advanced antibody performance and multiple detection technologies.

Actin, Smooth Muscle (1A4)
Beta-catenin (I4)
Calponin-1 (EP798Y)
Cytokeratin 14 (SP53)
Cytokeratin 5/6 (D5/16B4)
E-cadherin (36), CONFIRM
E-cadherin (EP700Y)
Estrogen Receptor (ER) (SP1), CONFIRM
FoxA1 (2F-83)
GATA3 (L50-823)
GCDFP-15 (EP1582Y)
HER2 Dual ISH DNA Probe Cocktail assay, INFORM
HER-2/neu (4B5), PATHWAY
HER-2/neu (4B5), VENTANA
IGF-1R (G11)
Ki-67 (30-9), CONFIRM
p120 (98)
p53 (DO-7), CONFIRM
p63 (4A4)
Progesterone Receptor (PR) (1E2),CONFIRM
TAG-72 (B72.3)
Topoisomerase IIa (JS5B4), CONFIRM

CINtec® PLUS p16/Ki-67 dual stain (Cytology) (E6H4™ and 274-11 AC3)
CINtec® p16 Histology (E6H4)

Beta-catenin (14)
BRAF-V600E (VE1)
c-KIT (9.7), PATHWAY
Cadherin 17 (SP183)
CEA (TF3H8-1)
CEA (CEA31)
CDX-2 (EPR2764Y)
COX-2 (SP21)
Cytokeratin 7 (SP52), CONFIRM
Cytokeratin 19 (A53-B/A2.26)
Cytokeratin 20 (SP33), CONFIRM
DOG1 (SP31)
Glutamine Synthetase (GS-6)
Helicobacter pylori (SP48), VENTANA
MLH-1 (M1)
MSH2 (G219-1129)
MSH6 (44), CONFIRM
MUC1 (H23)
MUC2 (MRQ-18)
PMS2 (EPR3947)

Albumin, FITC a-1-Antichymotrypsin (ACT)
a-1-Antitrypsin (AAT)
CEA (CEA31)
Carcinoembryonic Antigen (CEA) (TF3H8-1)
CD2 (MRQ-11)
CD3 (2GV6), CONFIRM
CD31 (JC70)
CD34 (QBEnd/10), CONFIRM
CD63 (NKI/C3)
Cytokeratin (34bE12), CONFIRM
Cytokeratin (AE1), CONFIRM
Cytokeratin 8 and 18 (B22.1 and B23.1), CONFIRM
Desmin (DE-R-11), CONFIRM
EMA (Epithelial Membrane Antigen) (E29), CONFIRM
Ep-CAM (Epithelial Specific Antigen) (Ber-EP4)
Factor VIII Related Antigen
Factor XIIIa (AC-1A1)
Factor XIIIa (EP3372)
C1q, FITC
C3, FITC
C4, FITC
Fibrinogen, FITC
Kappa, FITC Lambda, FITC
HHV-8 (Human Herpes Virus Type 8) (13B10)
IgA (Immunoglobulin A)
IgA (Immunoglobulin A), FITC
IgG (Immunoglobulin G)
IgG (Immunoglobulin G), FITC
IgM (Immunoglobulin M)
IgM (Immunoglobulin M), FITC
Macrophage (HAM-56)
MART-1/melan A (A103), CONFIRM
Melanoma Associated Antigen (KBA.62)
Melanoma Associated Antigen (PNL2)
Melanoma Triple Cocktail (A103, HMB45, T311)
Melanosome (HMB45), CONFIRM
MITF (C5/D5), CONFIRM
Neurofilament (2F11)
p53 (DO-7), CONFIRM
p53 (Bp53-11)
Podoplanin (D2-40)
S100 (4C4.9), CONFIRM
S100 (Polyclonal), CONFIRM
SOX-10 (SP267)
Synaptophysin (MRQ-40)
Synaptophysin (SP11), CONFIRM
Tryptase (G3)
Tyrosinase (T311), CONFIRM
Vimentin (V9), CONFIRM
Vimentin (Vim 3B4), CONFIRM

ALK1 (ALK01), CONFIRM
Annexin A1 (MRQ-3)
bcl-2 (SP66)
bcl-2 (124), CONFIRM
bcl-6 (GI191E/A8)
BOB.1 (SP92)
c-Myc (Y69)
CD1a (EP3622)
CD2 (MRQ-11)
CD3 (2GV6), CONFIRM
CD4 (SP35), CONFIRM
CD5 (SP19), CONFIRM
CD7 (SP94)
CD8 (SP57)
CD10 (SP67), VENTANA
CD13 (SP187)
CD14 (EPR3653)
CD15 (MMA), CONFIRM
CD16 (SP175)
CD20 (L26), CONFIRM
CD22 (SP104)
CD23 (SP23), CONFIRM
CD25 (4C9)
CD30 (Ber-H2)
CD31 (JC70)
CD34 (QBEnd/10), CONFIRM
CD38 (SP149)
CD43 (L60)
CD45 (LCA) (2B11 and PD7/26)
CD45 (LCA) (RP2/18), CONFIRM
CD45R (MB1)
CD45RO (UCHL-1), CONFIRM
CD56 (123C3), CONFIRM
CD56 (MRQ-42)
CD57 (NK-1)
CD61 (2f2)
CD68 (KP-1), CONFIRM
CD71 (MRQ-48)
CD79a (SP18), CONFIRM
CD99 (O13), CONFIRM
CD138 (Syndecan-1) (B-A38)
Cyclin D1 (SP4-R)
Fascin (55k-2)
FoxP1 (SP133)
Galectin-3 (9C4)
Glycophorin A (GA-R2)
Granzyme B
Hemoglobin A (SP212)
HGAL (MRQ-49)
IgA (Immunoglobulin A)
IgD (Immunoglobulin D)
IgG (Immunoglobulin G)
IgM (Immunoglobulin M)
Kappa, CONFIRM
Lambda, CONFIRM
LMO2 (1A9-1), CONFIRM
LMO2 (SP51)
Lysozyme
MUM1 (MRQ-43)
Myeloperoxidase
Oct-2 (MRQ-2)
PAX5 (SP34), CONFIRM
PD-1 (NAT-105)
SOX-11 (MRQ-58)
Spectrin (RBC2/3D5)
T-bet (MRQ-46)
TdT
TRAcP (9C5)
ZAP-70 (2F3.2)

ALK (D5F3), VENTANA
c-MET Total (SP44), CONFIRM
Calretinin (SP65), CONFIRM
Carcinoembryonic Antigen (CEA) (TF3H8-1)
Caveolin-1 (SP43)
CD56 (123C3), CONFIRM
CD56 (MRQ-42)
CEA (CEA31)
Chromogranin A (LK2H10)
Cytokeratin (CAM 5.2)
Cytokeratin 5 (SP27)
Cytokeratin 5/6 (D5/16B4)
Cytokeratin 5/14 (EP1601Y/LL002)
Cytokeratin 7 (SP52), CONFIRM
Cytokeratin 17 (SP95)
Cytokeratin 20 (SP33), CONFIRM
E-cadherin (36), VENTANA
E-cadherin (EP700Y)
EGFR E746-A750 del (SP111)
EGFR (Epidermal Growth Factor Receptor) (5B7), CONFIRM
EGFR (Epidermal Growth Factor Receptor) (3C6), CONFIRM
EGFR L858R (SP125)
EMA (Epithelial Membrane Antigen) (E29), CONFIRM
Epithelial-Related Antigen (MOC-31)
Epithelial-Specific Antigen/Ep-CAM (Ber-EP4)
IGF-1R(G11), CONFIRM
Mesothelial Cell HBME-1 (HBME-1)
MUC1 (H23)
Napsin A (MRQ-60)
NSE (MRQ-55)
p40 (BC28)
p63 (4A4), VENTANA
Pan Keratin (AE1/AE3/PCK26) Primary Antibody
PD-L1 (SP263), VENTANA
SOX-2 (SP76)
Synaptophysin (MRQ-40)
Synaptophysin (SP11), CONFIRM
TAG-72 (B72.3)
Thyroid Transcription Factor-1 (8G7G3/1), CONFIRM
Thyroid Transcription Factor-1 (SP141) WT1 (6F-H2)

Androgen Receptor (SP107)
Basal Cell Cocktail (34ßE12+p63), VENTANA
Cytokeratin 5/6 (D5/16B4)
Cytokeratin 7 (SP52), CONFIRM
Cytokeratin 20 (SP33), CONFIRM
ERG (EPR3864)
EZH2 (SP129)
p63 (4A4), VENTANA
PSA, CONFIRM
PSA (ER-PR8)
PSAP (PASE/4LJ)